Nuenen, H.M.C. van

disease patient microbiota activity ibd patients metabolite bowel disease production effect bacteria colon faecal model bowel study inulin concentration -10 epithelial cells chapter epithelial result lacti system capsule treatment experiment composition control macrophage therapy caco -2 cells group barrier intestine individual crohn sample butyrate function gastroenterol barrier function figure il -10 compound number mucosal cytokine ileal addition inflammation faece delivery increase macfarlane gt survival ammonia cd-active patients lactate eudragit fs 30 response coliti microorganism amount content cd-active remission health condition eudragit l 30d faecal microbiota secretion hil -10 protein nh 4+ table macfarlane luminal mucosa infliximab